Neogenomics Laboratories Inc

General

Total Cases6
Active Cases3
Patents6
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
L1
D
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
02/12/25
Motions Submitted: [364] MOTION to Modify the Court's Construction of the Claim Term "Sequencing the Amplicons" to Chief/Senior District Judge CATHERINE C. EAGLES- (rw) (Entered: 02/12/2025)
02/12/25
TEXT ORDER issued by Chief/Senior District Judge CATHERINE C. EAGLES on 2/12/25. The Court has reviewed the parties Interim status report. Doc. [382] . It requires no action. If the parties are unable to resolve remaining discovery disputes, a motion is required. The trial is scheduled to begin on October 13, 2025, which is a federal holiday. The Court therefore will conduct jury selection and allow opening statements on Friday, October 10, 2025, with evidence to begin on Tuesday, October 14, 2025. Counsel should hold open October 10-21, 2025, for trial; the court remains of the tentative view that the case can be tried fairly during the week of October 14, but will make a final decision on trial time later, after any summary judgment briefing.(rw) (Entered: 02/12/2025)
02/11/25
REPLY, filed by Defendant NEOGENOMICS LABORATORIES, INC., to Response to [364] MOTION to Modify the Court's Construction of the Claim Term "Sequencing the Amplicons" filed by NEOGENOMICS LABORATORIES, INC.. (MORROW, JOHN) (Entered: 02/11/2025)
02/07/25
JOINT STATUS REPORT filed by all parties. Est. Trial Days: tbd. (Attachments: # [1] Exhibit 1. Emails re Jamal-Hanjani Depo, # [2] Exhibit 2. Emails re Swanton Depo, # [3] Exhibit 3. Emails re Depo limits)(SHORES, ANDREW) (Entered: 02/07/2025)
02/03/25
DECLARATION of Niall Lennon, Ph.D re [380] Brief Responsive Claim Construction Brief by Defendant NEOGENOMICS LABORATORIES, INC.. (Attachments: # [1] Exhibit 13 - Dr. Niall Lennon 1/30/2025 Deposition Transcript, # [2] Exhibit 14 - Kozarewa et al., PMC Author manuscript)(KREEGER, MATTHEW) (Entered: 02/03/2025)
02/03/25
Defendant Neogenomics Laboratories, Inc.s Responsive Claim Construction BRIEF re [373] Brief . (Attachments: # [1] Exhibit A - Excerpt of Oxford Dictionary)(KREEGER, MATTHEW) (Entered: 02/03/2025)
02/03/25
DECLARATION of Dr. Michael Metzker filed by Plaintiff NATERA, INC. re [378] Response, in support of Responsive Claim Construction Brief filed by NATERA, INC.. (Attachments: # [1] Exhibit 1. Illumina 2010 sequencing, # [2] Exhibit 2. Illumina 2008 datasheet, # [3] Exhibit 3. 2010 Illumina datasheet, # [4] Exhibit 4. Illumina 2014 - Understanding Q Scores, # [5] Exhibit 5. Bentley 2008, # [6] Exhibit 6. Sinha 2017, # [7] Exhibit 7. Akhras 2007)(SHORES, ANDREW) (Entered: 02/03/2025)
02/03/25
RESPONSE re [373] Brief re 596 Patent Claim Construction filed by NATERA, INC.. Replies due by 2/3/2025 (Attachments: # [1] Exhibit 1. D. Del. 18-cv-1019 Dkt, # [2] Exhibit 2. NeoGenomics IPR Petition for 596 Patent, # [3] Exhibit 3. Lennon Decl - 596 IPR Petition, # [4] Exhibit 4. Lennon Depo Tr. 01302025, # [5] Exhibit 5. Forshew 30b6 Depo Tr.)(SHORES, ANDREW) (Entered: 02/03/2025)
01/30/25
INTERIM REPORT OF MEDIATOR from Mark LeHocky - Mediation Held on 7/24/2024. (RECESS; Follow up mediation to take place by 06/13/2025) (mb) (Entered: 01/30/2025)
01/28/25
RESPONSE in Opposition re [364] MOTION to Modify the Court's Construction of the Claim Term "Sequencing the Amplicons" filed by NEOGENOMICS LABORATORIES, INC. filed by NATERA, INC.. Replies due by 2/11/2025 (SHORES, ANDREW) (Entered: 01/28/2025)